Impact of irbesartan, blood pressure control, and proteinuria on renal outcomes in the Irbesartan Diabetic Nephropathy Trial

LAWRENCE G HUNSICKER; ROBERT C ATKINS; JULIA B LEWIS; GREGORY BRADEN; PAUL J CHAMPION DE CRESPIGNY; GIACOMO DEFERRARI; PAUL DRURY; FRANCESCO LOCATELLI; THOMAS B WIEGMANN; EDMUND J LEWIS

首页> 外文期刊>Kidney international. >Impact of irbesartan, blood pressure control, and proteinuria on renal outcomes in the Irbesartan Diabetic Nephropathy Trial

【24h】

Impact of irbesartan, blood pressure control, and proteinuria on renal outcomes in the Irbesartan Diabetic Nephropathy Trial

机译：厄贝沙坦糖尿病肾病试验中厄贝沙坦，血压控制和蛋白尿对肾脏预后的影响

获取原文

获取外文期刊封面目录资料

开具论文收录证明 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Impact of irbesartan, blood pressure control, and proteinuria on renal outcomes in the Irbesartan Diabetic Nephropathy Trial.BackgroundIt is important to know the reliability of early changes in proteinuria in predicting late renal outcomes. The IDNT was a trial in which treatment assignment, baseline and follow-up blood pressure determinations, and albumin/creatinine ratios (ACR), and renal outcomes were recorded.

机译：在厄贝沙坦糖尿病肾病试验中，厄贝沙坦，血压控制和蛋白尿对肾结局的影响。背景重要的是，要知道蛋白尿的早期变化在预测晚期肾结局方面的可靠性。 IDNT是一项试验，其中记录了治疗分配，基线和后续血压测定，白蛋白/肌酐比值（ACR）和肾脏结局。

著录项

来源
《Kidney international.》 |2004年第s92期|共3页
作者
LAWRENCE G HUNSICKER; ROBERT C ATKINS; JULIA B LEWIS; GREGORY BRADEN; PAUL J CHAMPION DE CRESPIGNY; GIACOMO DEFERRARI; PAUL DRURY; FRANCESCO LOCATELLI; THOMAS B WIEGMANN; EDMUND J LEWIS;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. [J] . Pohl MA, Blumenthal S, Cordonnier DJ, Journal of the American Society of Nephrology: JASN . 2005,第10期

机译：在厄贝沙坦糖尿病肾病试验中，血压控制和血管紧张素II受体阻滞对肾脏结局的独立和累加影响：临床意义和局限性。
2. Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial: Clinical Implications and Limitations [J] . Daniel J. Cordonnier, Eberhard Ritz, Edmund J. Lewis, Journal of the American Society of Nephrology: JASN . 2005,第10期

机译：血压控制和血管紧张素II受体阻滞对厄贝沙坦糖尿病肾病试验肾结局的独立和累加影响：临床意义和局限性
3. Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. [J] . Berl T, Hunsicker LG, Lewis JB, Journal of the American Society of Nephrology: JASN . 2005,第7期

机译：在厄贝沙坦糖尿病肾病试验中，达到的血压对心血管结局的影响。
4. Study Mechanisms of Low Protein Diet Supplemented with Ketoanalogs on Reducing Proteinuria and Maintaining Nutritional Status in Type 2 Diabetic Nephropathy [C] . Ting Dong, Weijie Yuan, Jialin Wang, International Congress on Nutrition and Metabolism in Renal Disease . 2012

机译：酮甘露糖醛植物减少蛋白尿和维持2型糖尿病肾病营养状况的研究机制
5. IMMUNE COMPLEXES AND THE DEVELOPMENT OF DIABETIC NEPHROPATHY IN UNTREATED AND INSULIN-TREATED DIABETIC SYRIAN HAMSTERS (ALBUMINURIA, PROTEINURIA, IMMUNOGLOBULIN-G). [D] . QUENETTE, LINDA EKERN. 1984

机译：未经治疗和经胰岛素治疗的仓鼠（白蛋白，蛋白尿，免疫球蛋白-G）的免疫复合物和糖尿病性肾病的发展。
6. Blood Pressure Response to Zofenopril or Irbesartan Each Combined with Hydrochlorothiazide in High-Risk Hypertensives Uncontrolled by Monotherapy: A Randomized Double-Blind Controlled Parallel Group Noninferiority Trial [O] . Ettore Malacco, Stefano Omboni, Gianfranco Parati 2015

机译：单一疗法无法控制的高危高血压患者对佐非诺普利或厄贝沙坦联合氢氯噻嗪的血压反应：一项随机双盲对照平行组非劣效性试验
7. Impact of irbesartan, blood pressure control, and proteinuria on renal outcomes in the Irbesartan Diabetic Nephropathy Trial [O] . L.G. Hunsicker, R.C. Atkins, J.B. Lewis, G. Braden, P.J. de Crespigny, G. DeFerrari, P. Drury, F. Locatelli, T.B. Wiegmann, E.J. Lewis, Collaborative Study Group 2004

机译：厄贝沙坦糖尿病肾病试验中厄贝沙坦，血压控制和蛋白尿对肾脏预后的影响

Impact of irbesartan, blood pressure control, and proteinuria on renal outcomes in the Irbesartan Diabetic Nephropathy Trial

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅